Navigation Links
Better sharing of genetic information in human health
Date:9/12/2013

Montral, September 12, 2013 Since the sequence map of the human genome, the cost of sequencing the genome of an individual has fallen rapidly. This has resulted in a tremendous increase in the amount of human genomic data available to the international research community for the advancement of biomedical research. Yet, there is an absence of international mechanisms to support researchers in ensuring ethical and legal interoperability. In addition, the multiplicity and diversity of laws, standards and policies on sharing and accessing genetic and medical data represent major hurdles to international collaboration.

To address this gap, the Public Population Project in Genomics and Society (P3G), in partnership with the Centre of Genomics and Policy (CGP) at the McGill University and Gnome Qubec Innovation Centre, is proud to announce the launch of the IPAC, (International Policy interoperability and data Access Clearinghouse), a new resource to both promote the interoperability of international norms and to facilitate the sharing of clinical and research data.

Building on the expertise of P3G and the CGP, the IPAC will offer a "one-stop" service for national and international collaborative research projects. It will provide normative tools and frameworks that respect the laws and regulations of each country while facilitating access.

"As a policy interoperability tool provider and a data access broker, the IPAC will harmonize projects to ensure successful ethics, privacy and access review, thereby reducing unnecessary bureaucracy and delays," said Professor Bartha Maria Knoppers, co-founder of P3G, Canada Research Chair in Law and Medicine and Director of the Centre of Genomics and Policy.

"We applaud the development of new resources that serve to advance research in Qubec. IPAC is a great example of how concerted, forward-looking action can help to meet current and future challenges in genomic research and enhance the capacity for action and influence of Qubec research on the international scene," explained Jean-Franois Lise, Minister of International Relations, La Francophonie and External Trade.

Located in Montral at the McGill University and Gnome Qubec Innovation Centre, the IPAC will provide the international scientific community with the expertise and ethical frameworks needed to create an information clearinghouse and support structure.

"Gnome Qubec has always encouraged international collaborations, since they are critical to the advancement of genomic research. This confirms just how important it is to support projects like P3G, the driving force behind the IPAC resource. We are pleased to be able to leverage its activities of recent years in support of the scientific community," said Marc LePage, President and CEO of Gnome Qubec.

"McGill University is proud to be a founding partner of IPAC, and we thank P3G, CGP, and Professor Knoppers for their leadership on this important initiative," said Dr. Rose Goldstein, McGill's Vice-Principal (Research and International Relations). "International partnerships and interdisciplinary research are fundamental to McGill's research enterprise. We believe that by helping world-class researchers to work more collaboratively, regardless of discipline or country, we ensure that the strongest ideas will be applied to the transformative field of genomics."


'/>"/>

Contact: Éva Kammer
ekammer@genomequebec.com
514-519-6910
Gnome Qubec
Source:Eurekalert

Related biology news :

1. Better tests for liver toxicity would mean more medicines -- and safer medicines -- for patients
2. LSUHSC researchers develop new system to better study behavior, cell function
3. Better hygiene in wealthy nations may increase Alzheimers risk
4. UF scientists encounter holes in tree of life, push for better data storage
5. Better insight into molecular interactions
6. Study finds physicians need to better recognize use of herbal supplements while breastfeeding
7. Bigger lungs may be better for transplants
8. Androforte for Low T is Better Absorbed and More Economical than Androgel or Testim!
9. New technologies and ingredients provide better options for gluten-free eating
10. Trapping T-rays for better security scanners
11. Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global synthetic-biology ... $11.4 billion by 2021, growing at a compound annual growth ... An overview of the global markets for synthetic biology. - ... for 2016, and projections of compound annual growth rates (CAGRs) ...
(Date:2/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... present at the LEERINK Partners 6th Annual Global Healthcare ... Wednesday, February 15, 2017 at 10 a.m. Eastern Time. ... can be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Park ... free AFM Luncheon for all SPIE attendees and Park customers ... just one block from the San Jose Convention Center. The luncheon will feature ...
(Date:2/22/2017)... ON (PRWEB) , ... February 22, 2017 , ... ... on discovery and development of precision treatments for neurodegenerative diseases, today announced it ... validate the ProMIS approach.” This is one of a series of commentaries from ...
(Date:2/22/2017)... , Feb. 22, 2017 Origin (Origin Agritech, LLC, ... trait and seed provider, and Arcadia (Arcadia ... that develops and commercializes agricultural productivity traits and nutritional products, today ... corn biotechnology product developed in China to ... regulatory trials. ...
(Date:2/22/2017)... and SAN DIEGO , Feb. ... "Company") (OTCQB:CELZ) announced today expansion of its translational ... cell product through establishment of laboratory facilities in ... at the San Diego BioLabs facility, a biotechnology ... Novartis, and Sanofi. In November 2016, ...
Breaking Biology Technology: